Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5206042
Max Phase: Preclinical
Molecular Formula: C27H33N3O
Molecular Weight: 415.58
Associated Items:
ID: ALA5206042
Max Phase: Preclinical
Molecular Formula: C27H33N3O
Molecular Weight: 415.58
Associated Items:
Canonical SMILES: C/C(=C\C(=O)NC[C@@H]1C[C@@H]2C3C=CC=C4C3C(=CN4C)C[C@H]2N(C)C1)c1ccccc1
Standard InChI: InChI=1S/C27H33N3O/c1-18(20-8-5-4-6-9-20)12-26(31)28-15-19-13-23-22-10-7-11-24-27(22)21(17-30(24)3)14-25(23)29(2)16-19/h4-12,17,19,22-23,25,27H,13-16H2,1-3H3,(H,28,31)/b18-12+/t19-,22?,23+,25+,27?/m0/s1
Standard InChI Key: JNTUKHYQJLXAJR-WQZPKWQNSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 415.58 | Molecular Weight (Monoisotopic): 415.2624 | AlogP: 4.06 | #Rotatable Bonds: 4 |
Polar Surface Area: 35.58 | Molecular Species: BASE | HBA: 3 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 10.12 | CX LogP: 2.71 | CX LogD: -0.53 |
Aromatic Rings: 1 | Heavy Atoms: 31 | QED Weighted: 0.75 | Np Likeness Score: 0.68 |
1. Johnson JW, Ellis MJ, Piquette ZA, MacNair C, Carfrae L, Bhando T, Ritchie NE, Saliba P, Brown ED, Magolan J.. (2022) Antibacterial Activity of Metergoline Analogues: Revisiting the Ergot Alkaloid Scaffold for Antibiotic Discovery., 13 (2.0): [PMID:35178184] [10.1021/acsmedchemlett.1c00648] |
Source(1):